FDA OKs Compass dosimetry device

The U.S. Food and Drug Administration (FDA) has given 510(k) clearance to Stockholm-based RaySearch Laboratories and Ion Beam Applications (IBA) of Louvain-la-Neuve, Belgium, for their jointly developed Compass dosimetry device.

Compass is designed to enable medical staff to measure and reconstruct in 3D the radiation dose that was delivered to a patient during the course of treatment.

Related Reading

IBA sells cyclotron to Saudi Arabia, December 4, 2007

IBA, PETLinQ acquire SourceMedical's radiology division, November 26, 2007

IBA to acquire full interest in CIS Bio, September 14, 2007

IBA buries proton hatchet with Optivus, Loma Linda, August 21, 2007

IBA to equip fourth U.S. proton therapy center, July 25, 2007

Copyright © 2007 AuntMinnie.com

Page 1 of 461
Next Page